JP2008516969A5 - - Google Patents

Download PDF

Info

Publication number
JP2008516969A5
JP2008516969A5 JP2007536923A JP2007536923A JP2008516969A5 JP 2008516969 A5 JP2008516969 A5 JP 2008516969A5 JP 2007536923 A JP2007536923 A JP 2007536923A JP 2007536923 A JP2007536923 A JP 2007536923A JP 2008516969 A5 JP2008516969 A5 JP 2008516969A5
Authority
JP
Japan
Prior art keywords
composition
optionally substituted
propyl
dione
trihydropurine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007536923A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008516969A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/036950 external-priority patent/WO2006044610A1/en
Publication of JP2008516969A publication Critical patent/JP2008516969A/ja
Publication of JP2008516969A5 publication Critical patent/JP2008516969A5/ja
Pending legal-status Critical Current

Links

JP2007536923A 2004-10-15 2005-10-14 A2bアデノシン受容体アンタゴニストを使用した、気道のリモデリングおよび肺の炎症の予防および処置の方法 Pending JP2008516969A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61943904P 2004-10-15 2004-10-15
PCT/US2005/036950 WO2006044610A1 (en) 2004-10-15 2005-10-14 Method of preventing and treating airway remodeling and pulmonary inflammation using a2b adenosine receptor antagonists

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011277345A Division JP2012056965A (ja) 2004-10-15 2011-12-19 A2bアデノシン受容体アンタゴニストを使用した、気道のリモデリングおよび肺の炎症の予防および処置の方法

Publications (2)

Publication Number Publication Date
JP2008516969A JP2008516969A (ja) 2008-05-22
JP2008516969A5 true JP2008516969A5 (cg-RX-API-DMAC7.html) 2009-12-24

Family

ID=35677798

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007536923A Pending JP2008516969A (ja) 2004-10-15 2005-10-14 A2bアデノシン受容体アンタゴニストを使用した、気道のリモデリングおよび肺の炎症の予防および処置の方法
JP2011277345A Withdrawn JP2012056965A (ja) 2004-10-15 2011-12-19 A2bアデノシン受容体アンタゴニストを使用した、気道のリモデリングおよび肺の炎症の予防および処置の方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011277345A Withdrawn JP2012056965A (ja) 2004-10-15 2011-12-19 A2bアデノシン受容体アンタゴニストを使用した、気道のリモデリングおよび肺の炎症の予防および処置の方法

Country Status (13)

Country Link
US (2) US20060159627A1 (cg-RX-API-DMAC7.html)
EP (2) EP2311462A1 (cg-RX-API-DMAC7.html)
JP (2) JP2008516969A (cg-RX-API-DMAC7.html)
KR (1) KR20070063548A (cg-RX-API-DMAC7.html)
CN (1) CN101039677A (cg-RX-API-DMAC7.html)
AU (1) AU2005295654B2 (cg-RX-API-DMAC7.html)
CA (1) CA2583986A1 (cg-RX-API-DMAC7.html)
IL (1) IL182493A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007004373A (cg-RX-API-DMAC7.html)
NO (1) NO20072466L (cg-RX-API-DMAC7.html)
NZ (2) NZ589657A (cg-RX-API-DMAC7.html)
RU (1) RU2391103C2 (cg-RX-API-DMAC7.html)
WO (1) WO2006044610A1 (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE47351E1 (en) 1999-06-22 2019-04-16 Gilead Sciences, Inc. 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists
US6403567B1 (en) * 1999-06-22 2002-06-11 Cv Therapeutics, Inc. N-pyrazole A2A adenosine receptor agonists
CA2671940A1 (en) 2000-02-23 2001-08-30 Cv Therapeutics, Inc. Identification of partial agonists of the a2a adenosine receptor
WO2004011010A1 (en) * 2002-07-29 2004-02-05 Cv Therapeutics, Inc. Myocardial perfusion imaging using a2a receptor agonists
EP1658291B1 (en) * 2003-08-25 2013-10-02 Dogwood Pharmaceuticals, Inc. Substituted 8-heteroaryl xanthines
EP1802317A2 (en) * 2004-10-20 2007-07-04 Cv Therapeutics, Inc. Use of a2a adenosine receptor agonists
US7598379B2 (en) * 2005-02-25 2009-10-06 Pgx Health, Llc Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines
WO2006091897A2 (en) * 2005-02-25 2006-08-31 Adenosine Therapeutics, Llc Derivatives of 8-substituted xanthines
WO2006091898A2 (en) * 2005-02-25 2006-08-31 Adenosine Therapeutics, Llc Pyrazolyl substituted xanthines
CA2612344A1 (en) * 2005-06-16 2006-12-28 Cv Therapeutics, Inc. Prodrugs of a2b adenosine receptor antagonists
CA2636990A1 (en) * 2006-01-13 2007-07-26 Battelle Memorial Institute Animal model for assessing copd-related diseases
CA2640089C (en) 2006-02-03 2013-07-23 Cv Therapeutics, Inc. Process for preparing an a2a-adenosine receptor agonist and its polymorphs
US7884100B2 (en) * 2006-06-16 2011-02-08 Pgxhealth, Llc Substituted 8-[6-amino-3-pyridyl]xanthines
US7767685B2 (en) * 2006-06-29 2010-08-03 King Pharmaceuticals Research And Development, Inc. Adenosine A2B receptor antagonists
US20090081120A1 (en) * 2006-09-01 2009-03-26 Cv Therapeutics, Inc. Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods
MX2009002299A (es) * 2006-09-01 2009-03-20 Cv Therapeutics Inc Metodos y composiciones para incrementar la tolerancia del paciente durante metodos de formacion de imagenes del miocardio.
WO2008042796A2 (en) * 2006-09-29 2008-04-10 Cv Therapeutics, Inc. Methods for myocardial imaging in patients having a history of pulmonary disease
EP2099360A2 (en) * 2007-01-03 2009-09-16 CV Therapeutics Inc. Myocardial perfusion imaging
JP5460690B2 (ja) * 2008-03-26 2014-04-02 アドヴィナス・セラピューティックス・リミテッド アデノシンレセプターアンタゴニストとしてのヘテロ環化合物
KR20110063556A (ko) * 2008-09-29 2011-06-10 길리애드 사이언시즈, 인코포레이티드 다검출 전산화 단층 촬영법에 사용하기 위한 a-2-알파 수용체 길항제와 속도 조절제의 조합물
BRPI1009398A2 (pt) * 2009-03-13 2016-03-08 Advinus Therapeutics Private Ltd compostos de pirimidina fundida substituída
KR20130088834A (ko) * 2010-06-30 2013-08-08 길리애드 사이언시즈, 인코포레이티드 폐 고혈압의 치료를 위한 a2b 아데노신 수용체 길항제의 용도
AR085942A1 (es) 2011-04-07 2013-11-06 Gilead Sciences Inc Uso de receptor de aadenosina para tratar la insuficiencia cardiaca y la arritmia en pacientes posinfarto de miocardio
CN107249630A (zh) * 2014-11-24 2017-10-13 国家健康与医学研究院 通过il‑20r的拮抗作用治疗慢性阻塞性肺疾病的急性加重
ES2580702B1 (es) 2015-02-25 2017-06-08 Palobiofarma, S.L. Derivados de 2-aminopiridina como antagonistas del receptor A2b de adenosina y ligandos del receptor MT3 de melatonina
JP7849948B2 (ja) 2018-03-05 2026-04-22 テオン セラピューティクス,インク. アデノシン受容体アンタゴニストおよびその使用
EP4211135A1 (en) * 2020-09-04 2023-07-19 Teon Therapeutics, Inc. Cocrystals of an adenosine a2b receptor antagonist

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4326525A (en) 1980-10-14 1982-04-27 Alza Corporation Osmotic device that improves delivery properties of agent in situ
US5364620A (en) 1983-12-22 1994-11-15 Elan Corporation, Plc Controlled absorption diltiazem formulation for once daily administration
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US4992445A (en) 1987-06-12 1991-02-12 American Cyanamid Co. Transdermal delivery of pharmaceuticals
US5001139A (en) 1987-06-12 1991-03-19 American Cyanamid Company Enchancers for the transdermal flux of nivadipine
US4902514A (en) 1988-07-21 1990-02-20 Alza Corporation Dosage form for administering nilvadipine for treating cardiovascular symptoms
US5854081A (en) 1996-06-20 1998-12-29 The University Of Patent Foundation Stable expression of human A2B adenosine receptors, and assays employing the same
US6117878A (en) * 1998-02-24 2000-09-12 University Of Virginia 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
US6545002B1 (en) 1999-06-01 2003-04-08 University Of Virginia Patent Foundation Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors
US6815446B1 (en) 1999-08-31 2004-11-09 Vanderbilt University Selective antagonists of A2B adenosine receptors
BR0013673A (pt) * 1999-08-31 2002-05-28 Univ Vanderbilt Antagonistas seletivos de receptores de adenosina a2b
IL133680A0 (en) * 1999-09-10 2001-04-30 Can Fite Technologies Ltd Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
US6894021B2 (en) 2000-02-17 2005-05-17 Cv Therapeutics, Inc. Method for identifying and using A2B adenosine receptor antagonists to mediate mammalian cell proliferation
US6387913B1 (en) * 2000-12-07 2002-05-14 S. Jamal Mustafa Method of treating airway diseases with combined administration of A2B and A3 adenosine receptor antagonists
US20030235555A1 (en) * 2002-04-05 2003-12-25 David Shealey Asthma-related anti-IL-13 immunoglobulin derived proteins, compositions, methods and uses
US7304070B2 (en) 2001-11-09 2007-12-04 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US7125993B2 (en) * 2001-11-09 2006-10-24 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US20080318983A1 (en) 2001-11-09 2008-12-25 Rao Kalla A2b adenosine receptor antagonists
US7317017B2 (en) 2002-11-08 2008-01-08 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US6977300B2 (en) * 2001-11-09 2005-12-20 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
AU2002359365B2 (en) * 2001-11-09 2008-07-10 Gilead Sciences, Inc. A2B adenosine receptor antagonists
US6933298B2 (en) * 2001-12-08 2005-08-23 Aventis Pharma Deutschland Gmbh Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides and the use thereof for selectively inhibiting collagenases
KR20040068317A (ko) * 2001-12-20 2004-07-30 오에스아이 파마슈티컬스, 인코포레이티드 피리미딘 a₂b 선택성 길항 화합물, 그의 합성 방법 및용도
ES2229928B1 (es) 2003-10-02 2006-07-01 Almirall Prodesfarma, S.A. Nuevos derivados de pirimidin-2-amina.
US7449473B2 (en) 2003-10-31 2008-11-11 Cv Therapeutics, Inc. Substituted pyrrolo[3,2-d]pyrimidin-2,4-diones as A2b adenosine receptor antagonists
PL1789053T3 (pl) 2004-09-01 2012-12-31 Gilead Sciences Inc Sposób gojenia się rany wykorzystujący antagonistów receptora adenozynowego A2B
CA2612344A1 (en) 2005-06-16 2006-12-28 Cv Therapeutics, Inc. Prodrugs of a2b adenosine receptor antagonists
CA2646333C (en) 2006-03-17 2014-06-17 Cv Therapeutics, Inc. Method of preventing and treating hepatic disease using a2b adenosine receptor antagonists

Similar Documents

Publication Publication Date Title
RU2007117907A (ru) Способ предупреждения и лечения ремоделирования дыхательных путей и воспаления легких с применением антагонистов аденозиновых рецепторов a2b
CN101405003B (zh) 利用a2b腺苷受体拮抗剂预防和治疗肝病的方法
JP2005509036A5 (cg-RX-API-DMAC7.html)
CA2466477A1 (en) A2b adenosine receptor antagonists
JP6615109B2 (ja) Dpp−4阻害薬の医学的使用
KR102347721B1 (ko) 섬유성 질환의 치료에 사용하기 위한 ppar 화합물
JP2014526501A5 (cg-RX-API-DMAC7.html)
CN103298466B (zh) 茶碱和非布索坦的联合治疗方法
WO2004010929A2 (en) METHODS FOR IMPROVEMENT OF LUNG FUNCTION USING TGF-β INHIBITORS
JP2006515316A5 (cg-RX-API-DMAC7.html)
US20080318983A1 (en) A2b adenosine receptor antagonists
JP2008511654A5 (cg-RX-API-DMAC7.html)
JP2006515316A (ja) A2bアデノシンレセプターアンタゴニストであるキサンチン誘導体
JP2013533882A5 (cg-RX-API-DMAC7.html)
TW201302203A (zh) A2b腺苷受體拮抗劑於在心肌梗塞後之病患內治療心衰竭及心律不整上之用途
JP2007519717A5 (cg-RX-API-DMAC7.html)
HRP20120712T1 (hr) Postupak zarastanja rana primjenom antagonista adenozinskog a2b receptora
CN103237548A (zh) A2b腺苷受体拮抗剂用于治疗肺高血压的应用
CN1897952B (zh) 中性白细胞增多抑制剂
CA2398007A1 (en) Use of pyrimidine endothelin antagonists in companion animals
Richards Thiazolidinedione‐Based Insulin Sensitizers: PPAR‐γ Agonists for the Treatment of Type 2 Diabetes
RU2005134232A (ru) Производные ксантина в качестве антагонистов а2в аденозинового рецептора
HK1156213A (en) Method of preventing and treating airway remodeling and pulmonary inflammation using a2b adenosine receptor antagonists